drugset / Trial / NCT00022555
Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
Phase I trial to study the effectiveness of bryostatin 1 plus vincristine in treating patients who have recurrent or refractory lymphoma. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Bryostatin 1 may help vincristine kill more cancer cells by making them more sensitive to the drug
Timeline
- Start
- 2001-11
- Primary completion
- 2003-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vincristine | Small molecule | — | Intravenous |
| Subject | bryostatin 1 | Small molecule | — | Intravenous |